Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 1 1

Status

Completed 21Terminated 6Unknown 4Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 2

Conditions

Sarcoma 10Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 4Leukemia 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Small Cell Lung Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Hodgkin Disease 3Central Nervous System Neoplasms 3Testicular Germ Cell Tumor 2Relapsed Pediatric Solid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, T-Cell, Peripheral 2Fallopian Tube Neoplasms 2Burkitt Lymphoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Unresectable Sinonasal Tumors 1Teratoma 1Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1Sinonasal Tumors 1Seminoma 1

Interventions

Cyclophosphamide 27Rituximab 20Etoposide 14Cytarabine 13Melphalan 11Vincristine 10fludarabine 9Prednisone 9Doxorubicin 9Busulfan 8Peripheral Blood Stem Cell Transplantation 7Radiotherapy 6Filgrastim 6Cyclosporine 6Bendamustine Hydrochloride 6fludarabine phosphate 5N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5Mycophenolic Acid 5Cisplatin 5tositumomab I-131 4ibritumomab tiuxetan 4Ifosfamide 4Dexamethasone 4Carmustine 4relmacabtagene autoleucel 3Thiotepa 3Indium 3Immunotherapy, Adoptive 3Gemcitabine 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Non-Hodgkin × Ifosfamide × Clear all
NCT00324467 2021-07-22

LYTPET

British Columbia Cancer Agency

Phase 2 Unknown
150 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT01148173 2010-06-22

High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas

Charite University, Berlin, Germany

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT00797810 2009-09-15

Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults

University of Bologna

Phase 4 Unknown
25 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00004086 2009-06-09

Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡